The Library
Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour
Tools
Tools
Tools
Onyema, Michael C., Drakou, Eftychia E., Giovos, Georgios, Leca, Bianca, Kosmas, Christos, Ganguly, Ratnadeep, Murthy, Narasimha, Grossman, Ashley B., Randeva, Harpal S. and Dimitriadis, Georgios K. (2020) Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour. Endocrine and Metabolic Science, 1 (1–2). 100047. doi:10.1016/j.endmts.2020.100047
|
PDF
WRAP-paraneoplastic-hypoglycaemia-secondary-IGF-2-secretion-metastatic-gastrointestinal-stromal-tumour-Dimitriadis-2020.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution Non-commercial No Derivatives 4.0. Download (1283Kb) | Preview |
|
![[img]](https://wrap.warwick.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
WRAP-paraneoplastic-hypoglycaemia-secondary-IGF-2-secretion-metastatic-gastrointestinal-stromal-tumour-Dimitriadis-2020.pdf - Accepted Version Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer. Download (829Kb) |
Official URL: http://dx.doi.org/10.1016/j.endmts.2020.100047
Abstract
We report the case of a 79-year-old male with previous history of non-Hodgkin's lymphoma in remission, who presented acutely to the Accident and Emergency department with recurrent episodes of hypoglycaemia. At the time of presentation, a random glucose was low at 1.4 mmol/l, which upon correction resolved his symptoms. In hindsight, the patient recalled having had similar episodes periodically over the past 2 months to which he did not give much notice. While hospitalized, he continued having episodes of symptomatic hypoglycaemia, requiring treatment with intravenous dextrose and per os steroids. Once stable, he was discharged on oral prednisolone and dietary advice. A computed tomography scan performed during inpatient stay showed multiple deposits in the abdomen. An ultrasound guided biopsy of one of the liver deposits was performed. Immunohistochemistry supported the diagnosis of a gastrointestinal stromal tumour (GIST) positive for CD34 and CD117. The diagnosis of non-islet cell tumour hypoglycaemia (NICTH) secondary to an IGF2 secreting GIST was confirmed with further biochemical investigations (IGF2=105.9 nmol/l; IGF2:IGF1 ratio 23, Upper Level of Normal (ULN) <10). Targeted cytoreductive treatment with Imatinib mesylate following assessment of the tumour's mutational status was successful in preventing hypoglycaemia over a 21-month follow-up observation period.
| Item Type: | Journal Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QP Physiology R Medicine > RC Internal medicine |
||||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||||
| Library of Congress Subject Headings (LCSH): | Paraneoplastic syndromes, Hypoglycemia, Giant cell tumors, Gastrointestinal system -- Tumors, Imatinib , Somatomedin | ||||||||
| Journal or Publication Title: | Endocrine and Metabolic Science | ||||||||
| Publisher: | Elsevier BV | ||||||||
| Official Date: | July 2020 | ||||||||
| Dates: |
|
||||||||
| Volume: | 1 | ||||||||
| Number: | 1–2 | ||||||||
| Article Number: | 100047 | ||||||||
| DOI: | 10.1016/j.endmts.2020.100047 | ||||||||
| Status: | Peer Reviewed | ||||||||
| Publication Status: | Published | ||||||||
| Access rights to Published version: | Open Access (Creative Commons) | ||||||||
| Date of first compliant deposit: | 16 April 2020 | ||||||||
| Date of first compliant Open Access: | 16 April 2020 |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
